These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7684994)

  • 1. CA-125: a marker for persistent gestational trophoblastic disease?
    Koonings PP; Schalerth JB
    Gynecol Oncol; 1993 May; 49(2):240-2. PubMed ID: 7684994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydatidiform moles.
    Heath JM; Bu TH; Brereton WF
    Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve.
    Yedema KA; Verheijen RH; Kenemans P; Schijf CP; Borm GF; Segers MF; Thomas CM
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):787-92. PubMed ID: 7681253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
    Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
    J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune system in disease: gestational trophoblastic tumours.
    Newlands ES; Fisher RA; Searle F
    Baillieres Clin Obstet Gynaecol; 1992 Sep; 6(3):519-39. PubMed ID: 1332835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P
    Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for gestational trophoblastic tumors following complete hydatidiform mole].
    Grzybowski W; Płoszyński A; Mielnik J; Adamcio-Deptulska M; Preis K; Wojciechowska D
    Ginekol Pol; 2002 Nov; 73(11):1003-10. PubMed ID: 12722390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of molar pregnancy and gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Hoch EJ; Anderson DJ
    J Reprod Med; 1984 Nov; 29(11):796-801. PubMed ID: 6097683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of gestational trophoblastic disease.
    Lewis JL
    Cancer; 1993 Feb; 71(4 Suppl):1639-47. PubMed ID: 8381709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide controversies in gestational trophoblastic neoplasms.
    Goldstein DP
    Int J Gynaecol Obstet; 1977; 15(3):207-15. PubMed ID: 205453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J; Rosenshein NB; Block BS
    Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydatidiform mole and persistent trophoblastic disease in adolescents.
    Parrish SK
    J Pediatr; 1986 Nov; 109(5):838-40. PubMed ID: 2430085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.